Retrospective Study of MIBG Therapy for Phaeochromocytoma (PH) and Paraganglioma (PG): The Christie Experience

#1002

Introduction: PH & PG are rare neuroendocrine tumors treated with MIBG but protocols are not standardized and reported results are variable.

Aim(s): Outcomes after MIBG therapy vary as there is no set protocol as to the dose or number of cycles given. We report results of seven pts receiving MIBG therapy for metastatic PH/PG.

Materials and methods: Retrospectively study: seven pts receiving MIBG [M/F 6/1 median age 31 yr] with metastatic PH (n=4) or PG (n=3) to evaluate efficacy tolerability & overall survival. Response assessed using clinical benefit biochemical markers and radiology.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Salih Z, Fletcher K, Clay V, Manoharan P, Hawkins R,

Keywords: mibg,